Marfan Syndrome and Quality of Life of Pediatric Patients
MarfanPed
Marfan Syndrome: the Impact on the Quality of Life, Phenotypic Manifestations on Self-image and Self-management Skills, as an Index of Adaptation to the Disease in Pediatric Patients
1 other identifier
observational
80
1 country
1
Brief Summary
The goal of this observational study is to learn about the impact of Marfan syndrome (MFS) in paediatric affected subjects. the main questions it aims to answer are:
- The assessment of quality of life in MFS Italian patients;
- The impact of phenotypic manifestations on self-image and self-management skills;
- Stratify patients according to the need of psychological support. Participants will take part in the study by completing four self-report questionnaires.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 9, 2023
CompletedFirst Submitted
Initial submission to the registry
January 26, 2023
CompletedFirst Posted
Study publicly available on registry
February 28, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2026
CompletedSeptember 10, 2025
September 1, 2025
3 years
January 26, 2023
September 8, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Psychological counseling
Questionnaire to assess psychological support is KINDL-R (Quality of life);
12 months
Psychological counseling
Questionnaire to assess psychological support is Multidimensional Self Concept Scale (MSCS)
12 months
Psychological counseling
Questionnaire to assess psychological support is Morisky Medication Adherence Scale
12 months
Interventions
KINDL-R; Morisky Medication Adherence Scale;
Eligibility Criteria
Subjects with clinical and/or genetic diagnosis od MFS currently in follow up at Cardiovascular Genetic Centre, IRCCS Policlinico San Donato
You may qualify if:
- Signed informed consent;
- MFS diagnosis according to Revised Ghent criteria (2010);
You may not qualify if:
- Known cognitive deficits
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
IRCCS Policlinico San Donato
San Donato Milanese, Lombardy, 20097, Italy
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alessandro Pini, MD
Cardiovascular-Gentic Centre, IRCCS Policlinico San Donato
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
January 26, 2023
First Posted
February 28, 2023
Study Start
January 9, 2023
Primary Completion
December 31, 2025
Study Completion
May 1, 2026
Last Updated
September 10, 2025
Record last verified: 2025-09